Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-8bljj Total loading time: 0 Render date: 2024-07-04T22:01:26.108Z Has data issue: false hasContentIssue false

Section 5 - Chronic Immune Neuropathies

Published online by Cambridge University Press:  20 April 2018

Mark B. Bromberg
Mark B. Bromberg
Affiliation:
University of Utah
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Peripheral Neuropathies
A Practical Approach
 , pp. 121 - 134
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision. J Peripher Nerv Syst. 2010;15(3):185–95.Google Scholar
Anderson, CR, Olson, JA. Correlation of weight-based i.v. immune globulin doses with changes in serum immunoglobulin G levels. Am J Health Syst Pharm. 2015;72(4):285–9.Google Scholar
Beydoun, SR, Muir, J, Apelian, RG, Go, JL, Lin, FP. Clinical and imaging findings in three patients with advanced inflammatory demyelinating polyradiculoneuropathy associated with nerve root hypertrophy. J Clin Neuromuscul Dis. 2012;13(3):105–12.CrossRefGoogle ScholarPubMed
Boru, UT, Erdogan, H, Alp, R, Tasdemir, M, Yildirim, S, Bilgic, A, et al. Treatment of chronic inflammatory demyelinating polyneuropathy with high dose intravenous methylprednisolone monthly for five years: 10-Year follow up. Clin Neurol Neurosurg. 2014;118:89–93.CrossRefGoogle Scholar
Breiner, A, Brannagan, TH, III. Comparison of sensitivity and specificity among 15 criteria for chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2014;50(1):40–6.Google Scholar
Bromberg, MB. Review of the evolution of electrodiagnostic criteria for chronic inflammatory demyelinating polyradicoloneuropathy. Muscle Nerve. 2011;43(6):780–94.Google Scholar
Bromberg, MB, Brownell, AA. Role of electroidagnosis in the evaluation of peripheral neuropathies. Intestbook of Peripheral Neuropathy, Donofrio PD (ed). New York: Demosmedical; 2012.Google Scholar
Bromberg, MB, Carter, O. Corticosteroid use in the treatment of neuromuscular disorders: empirical and evidence-based data. Muscle Nerve. 2004;30(1):20–37.Google Scholar
Bromberg, MB, Feldman, EL, Albers, JW. Chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients with and without an associated monoclonal gammopathy. Neurology. 1992;42(6):1157–63.Google Scholar
Cocito, D, Grimaldi, S, Paolasso, I, Falcone, Y, Antonini, G, Benedetti, L, et al. Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis. Eur J Neurol. 2011;18(12):1417–21.Google Scholar
Cornblath, DR, Gorson, KC, Hughes, RA, Merkies, IS. Observations on chronic inflammatory demyelinating polyneuropathy: A plea for a rigorous approach to diagnosis and treatment. J Neurol Sci. 2013;330(1–2):2–3.CrossRefGoogle ScholarPubMed
Di Pasquale, A, Morino, S, Loreti, S, Bucci, E, Vanacore, N, Antonini, G. Peripheral nerve ultrasound changes in CIDP and correlations with nerve conduction velocity. Neurology. 2015;84(8):803–809.Google Scholar
Dyck, PJ, Lais, AC, Ohta, M, Bastron, JA, Okazaki, H, Groover, RV. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc. 1975;50(11):621–37.Google ScholarPubMed
Eftimov, F, Vermeulen, M, van Doorn, PA, Brusse, E, van Schaik, IN. Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment. Neurology. 2012;78(14):1079–84.Google Scholar
Eftimov, F, Winer, JB, Vermeulen, M, de Haan, R, van Schaik, IN. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2013;12:CD001797.Google Scholar
Hughes, RA, Bouche, P, Cornblath, DR, Evers, E, Hadden, RD, Hahn, A, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol. 2006;13(4):326–32.Google Scholar
Hughes, RA, Donofrio, P, Bril, V, Dalakas, MC, Deng, C, Hanna, K, et al. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurol. 2008;7(2):136–44.CrossRefGoogle Scholar
Hughes, RA, Mehndiratta, MM. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2015;1:CD002062.Google Scholar
Jang, JH, Cho, CS, Yang, KS, Seok, HY, Kim, BJ. Pattern analysis of nerve enlargement using ultrasonography in chronic inflammatory demyelinating polyneuropathy. Clin Neurophysiol. 2014;125(9):1893–9.CrossRefGoogle ScholarPubMed
Lozeron, P, Lacour, MC, Vandendries, C, Theaudin, M, Cauquil, C, Denier, C, et al. Contribution of plexus MRI in the diagnosis of atypical chronic inflammatory demyelinating polyneuropathies. J Neurol Sci. 2016;360:170–5.CrossRefGoogle ScholarPubMed
Mahdi-Rogers, M, van Doorn, PA, Hughes, RA. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2013;6:CD003280.Google Scholar
Mathey, EK, Park, SB, Hughes, RA, Pollard, JD, Armati, PJ, Barnett, MH, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. J Neurol Neurosurg Psychiatry. 2015.CrossRefGoogle ScholarPubMed
Mehndiratta, MM, Hughes, RA. Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2012;9:CD003906.Google Scholar
Muley, SA, Kelkar, P, Parry, GJ. Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids. Arch Neurol. 2008;65(11):1460–4.Google Scholar
Querol, L, Rojas-Garcia, R, Casasnovas, C, Sedano, MJ, Munoz-Blanco, JL, Alberti, MA, et al. Long-term outcome in chronic inflammatory demyelinating polyneuropathy patients treated with intravenous immunoglobulin: a retrospective study. Muscle Nerve. 2013;48(6):870–6.Google Scholar
Rajabally, YA. Subcutaneous immunoglobulin therapy for inflammatory neuropathy: current evidence base and future prospects. J Neurol Neurosurg Psychiatry. 2014;85(6):631–7.Google Scholar
Rajabally, YA. Long-term Immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 2015;51(5):657–61.Google Scholar
Ruts, L, Drenthen, J, Jacobs, BC, van Doorn, PA. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study. Neurology. 2010;74(21):1680–6.CrossRefGoogle ScholarPubMed
Van den Bergh, PY, Hadden, RD, Bouche, P, Cornblath, DR, Hahn, A, Illa, I, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision. Eur J Neurol. 2010;17(3):356–63.Google Scholar

References

Ayrignac, X, Viala, K, Koutlidis, RM, Taieb, G, Stojkovic, T, Musset, L, et al. Sensory chronic inflammatory demyelinating polyneuropathy: an under-recognized entity? Muscle Nerve. 2013;48(5):727–32.Google Scholar
Dispenzieri, A. POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management. Am J Hematol. 2014;89(2):214–23.Google Scholar
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision. J Peripher Nerv Syst. 2010;15(3):185–95.Google Scholar
Katz, JS, Saperstein, DS, Gronseth, G, Amato, AA, Barohn, RJ. Distal acquired demyelinating symmetric neuropathy. Neurology. 2000;54(3):615–20.CrossRefGoogle ScholarPubMed
Magy, L, Kabore, R, Mathis, S, Lebeau, P, Ghorab, K, Caudie, C, et al. Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies. J Immunol Res. 2015;450391.Google ScholarPubMed
Nobile-Orazio, E. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go. J Peripher Nerv Syst. 2014;19(1):2–13.CrossRefGoogle ScholarPubMed
Thomas, PK, Claus, D, Jaspert, A, Workman, JM, King, RH, Larner, AJ, et al. Focal upper limb demyelinating neuropathy. Brain. 1996;119 (Pt 3):765–74.Google Scholar
Viala, K, Maisonobe, T, Stojkovic, T, Koutlidis, R, Ayrignac, X, Musset, L, et al. A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst. 2010;15(1):50–6.Google Scholar
Willison, HJ, O’Leary, CP, Veitch, J, Blumhardt, LD, Busby, M, Donaghy, M, et al. The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain. 2001;124(Pt 10):1968–77.Google Scholar

References

European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision. J Peripher Nerv Syst. 2010;15(4):295–301.Google Scholar
Kuwabara, S, Isose, S, Mori, M, Mitsuma, S, Sawai, S, Beppu, M, et al. Different electrophysiological profiles and treatment response in “typical” and “atypical” chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry. 2015;86(10):1054–9.Google Scholar
Leger, JM, Guimaraes-Costa, R, Iancu Ferfoglia, R. The pathogenesis of multifocal motor neuropathy and an update on current management options. Ther Adv Neurol Disord. 2015;8(3):109–22.Google Scholar
Van Asseldonk, JT, Van den Berg, LH, Van den Berg-Vos, RM, Wieneke, GH, Wokke, JH, Franssen, H. Demyelination and axonal loss in multifocal motor neuropathy: distribution and relation to weakness. Brain. 2003;126(Pt 1):186–98.Google Scholar
Bromberg, MB, Franssen, H. Practical rules for electrodiagnosis in suspected multifocal motor neuropathy. J Clin Neuromuscul Dis. 2015;16(3):141–52.Google Scholar
Olney, RK, Lewis, RA, Putnam, TD, Campellone, JV, Jr. Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve. 2003;27(1):117–21.CrossRefGoogle ScholarPubMed
Van Asseldonk, JT, Van den Berg, LH, Kalmijn, S, Van den Berg-Vos, RM, Polman, CH, Wokke, JH, et al. Axon loss is an important determinant of weakness in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry. 2006;77(6):743–7.Google Scholar
Lambrecq, V, Krim, E, Rouanet-Larriviere, M, Lagueny, A. Sensory loss in multifocal motor neuropathy: a clinical and electrophysiological study. Muscle Nerve. 2009;39(2):131–6.CrossRefGoogle ScholarPubMed
Capasso, M, Notturno, F, Manzoli, C, Uncini, A. Involvement of sensory fibres in axonal subtypes of Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry. 2011;82(6):664–70.Google Scholar
Kerasnoudis, A, Pitarokoili, K, Behrendt, V, Gold, R, Yoon, MS. Multifocal motor neuropathy: correlation of nerve ultrasound, electrophysiological, and clinical findings. J Peripher Nerv Syst. 2014;19(2):165–74.Google Scholar
Pitarokoili, K, Gold, R, Yoon, MS. Nerve ultrasound in a case of multifocal motor neuropathy without conduction block. Muscle Nerve. 2015;52(2):294–6.CrossRefGoogle Scholar
van Schaik, IN, van den Berg, LH, de Haan, R, Vermeulen, M. Intravenous immunoglobulin for multifocal motor neuropathy. Cochrane Database Syst Rev. 2005(2):CD004429.Google Scholar
Umapathi, T, Hughes, RA, Nobile-Orazio, E, Leger, JM. Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy. Cochrane Database Syst Rev. 2015;3:CD003217.Google Scholar
Delmont, E, Azulay, JP, Giorgi, R, Attarian, S, Verschueren, A, Uzenot, D, et al. Multifocal motor neuropathy with and without conduction block: a single entity? Neurology. 2006;67(4):592–6.Google Scholar
Lewis, RA, Sumner, AJ, Brown, MJ, Asbury, AK. Multifocal demyelinating neuropathy with persistent conduction block. Neurology. 1982;32(9):958–64.Google Scholar
Saperstein, DS, Amato, AA, Wolfe, GI, Katz, JS, Nations, SP, Jackson, CE, et al. Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome. Muscle Nerve. 1999;22(5):560–6.Google Scholar
Verschueren, A, Azulay, JP, Attarian, S, Boucraut, J, Pellissier, JF, Pouget, J. Lewis-Sumner syndrome and multifocal motor neuropathy. Muscle Nerve. 2005;31(1):88–94.Google Scholar
Attarian, S, Verschueren, A, Franques, J, Salort-Campana, E, Jouve, E, Pouget, J. Response to treatment in patients with Lewis-Sumner syndrome. Muscle Nerve. 2011;44(2):179–84.Google Scholar
Bayas, A, Gold, R, Naumann, M. Long-term treatment of Lewis-Sumner syndrome with subcutaneous immunoglobulin infusions. J Neurol Sci. 2013;324(1–2):53–6.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×